The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
Identifieur interne : 001452 ( PubMed/Curation ); précédent : 001451; suivant : 001453The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
Auteurs : B C L. Lai [Canada] ; M. Schulzer ; S. Marion ; K. Teschke ; J K C. TsuiSource :
- Parkinsonism & related disorders [ 1353-8020 ] ; 2003.
English descriptors
- KwdEn :
- Adult, Aged, Antiparkinson Agents (therapeutic use), British Columbia (epidemiology), Bromocriptine (therapeutic use), Data Interpretation, Statistical, Databases, Factual, Drug Prescriptions, Drug Utilization, Female, Humans, Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Sex Factors.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Bromocriptine, Levodopa.
- geographic , epidemiology : British Columbia.
- drug therapy : Parkinson Disease.
- epidemiology : Parkinson Disease.
- Adult, Aged, Data Interpretation, Statistical, Databases, Factual, Drug Prescriptions, Drug Utilization, Female, Humans, Male, Middle Aged, Sex Factors.
Abstract
To estimate the prevalence of Parkinson's disease (PD) in British Columbia utilizing the prescription database of the College of Pharmacists.
PubMed: 12618059
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001452
Links to Exploration step
pubmed:12618059Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.</title><author><name sortKey="Lai, B C L" sort="Lai, B C L" uniqKey="Lai B" first="B C L" last="Lai">B C L. Lai</name><affiliation wicri:level="1"><nlm:affiliation>Pacific Parkinson's Research Centre, Department of Medicine, Vancouver Hospital and Health Sciences Centre, The University of British Columbia, Purdy Pavilion 2221, Wesbrook Mall, Vancouver, BC, Canada V6T 2B5.</nlm:affiliation><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, Department of Medicine, Vancouver Hospital and Health Sciences Centre, The University of British Columbia, Purdy Pavilion 2221, Wesbrook Mall, Vancouver, BC</wicri:regionArea></affiliation></author><author><name sortKey="Schulzer, M" sort="Schulzer, M" uniqKey="Schulzer M" first="M" last="Schulzer">M. Schulzer</name></author><author><name sortKey="Marion, S" sort="Marion, S" uniqKey="Marion S" first="S" last="Marion">S. Marion</name></author><author><name sortKey="Teschke, K" sort="Teschke, K" uniqKey="Teschke K" first="K" last="Teschke">K. Teschke</name></author><author><name sortKey="Tsui, J K C" sort="Tsui, J K C" uniqKey="Tsui J" first="J K C" last="Tsui">J K C. Tsui</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12618059</idno><idno type="pmid">12618059</idno><idno type="wicri:Area/PubMed/Corpus">001452</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001452</idno><idno type="wicri:Area/PubMed/Curation">001452</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001452</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.</title><author><name sortKey="Lai, B C L" sort="Lai, B C L" uniqKey="Lai B" first="B C L" last="Lai">B C L. Lai</name><affiliation wicri:level="1"><nlm:affiliation>Pacific Parkinson's Research Centre, Department of Medicine, Vancouver Hospital and Health Sciences Centre, The University of British Columbia, Purdy Pavilion 2221, Wesbrook Mall, Vancouver, BC, Canada V6T 2B5.</nlm:affiliation><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, Department of Medicine, Vancouver Hospital and Health Sciences Centre, The University of British Columbia, Purdy Pavilion 2221, Wesbrook Mall, Vancouver, BC</wicri:regionArea></affiliation></author><author><name sortKey="Schulzer, M" sort="Schulzer, M" uniqKey="Schulzer M" first="M" last="Schulzer">M. Schulzer</name></author><author><name sortKey="Marion, S" sort="Marion, S" uniqKey="Marion S" first="S" last="Marion">S. Marion</name></author><author><name sortKey="Teschke, K" sort="Teschke, K" uniqKey="Teschke K" first="K" last="Teschke">K. Teschke</name></author><author><name sortKey="Tsui, J K C" sort="Tsui, J K C" uniqKey="Tsui J" first="J K C" last="Tsui">J K C. Tsui</name></author></analytic><series><title level="j">Parkinsonism & related disorders</title><idno type="ISSN">1353-8020</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>British Columbia (epidemiology)</term><term>Bromocriptine (therapeutic use)</term><term>Data Interpretation, Statistical</term><term>Databases, Factual</term><term>Drug Prescriptions</term><term>Drug Utilization</term><term>Female</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Sex Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Bromocriptine</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>British Columbia</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Data Interpretation, Statistical</term><term>Databases, Factual</term><term>Drug Prescriptions</term><term>Drug Utilization</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Sex Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To estimate the prevalence of Parkinson's disease (PD) in British Columbia utilizing the prescription database of the College of Pharmacists.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12618059</PMID><DateCreated><Year>2003</Year><Month>03</Month><Day>05</Day></DateCreated><DateCompleted><Year>2003</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1353-8020</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Parkinsonism & related disorders</Title><ISOAbbreviation>Parkinsonism Relat. Disord.</ISOAbbreviation></Journal><ArticleTitle>The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.</ArticleTitle><Pagination><MedlinePgn>233-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the prevalence of Parkinson's disease (PD) in British Columbia utilizing the prescription database of the College of Pharmacists.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients receiving anti-parkinsonian drug (anti-PD) prescriptions between 1996 and 1998 were stratified by year, age, gender, drug use category, and geographic location. The numbers of patients on levodopa alone, or levodopa and/or other anti-PD drugs were adjusted using published data which gave estimates of the proportion of undiagnosed patients with PD, the proportion of those treated for parkinsonism with definite PD, the proportion of patients with PD not being treated with anti-PD medications, and the proportion of patients treated with anti-PD medications who have PD. Use of the anti-PD drug bromocriptine for other purposes in women under 50 years of age was also considered.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The estimated prevalences of PD based on all anti-PD medications used were 109, 121, and 125 per 100,000 population in 1996, 1997, and 1998, respectively. Estimated prevalences of PD based on levodopa use were 126, 134, and 144, respectively. The prevalence in both prescription groups increased with age. The male to female ratio of prevalence ranged from 1.16 to 1.21.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using a large, accurate database, it is possible to estimate the prevalence of PD in a large population, though the assumptions built into the estimate remain to be validated in the subject population.</AbstractText><CopyrightInformation>Copyright 2003 Elsevier Science Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>B C L</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Pacific Parkinson's Research Centre, Department of Medicine, Vancouver Hospital and Health Sciences Centre, The University of British Columbia, Purdy Pavilion 2221, Wesbrook Mall, Vancouver, BC, Canada V6T 2B5.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulzer</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Marion</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Teschke</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>J K C</ForeName><Initials>JK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Parkinsonism Relat Disord</MedlineTA><NlmUniqueID>9513583</NlmUniqueID><ISSNLinking>1353-8020</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber><NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001971" MajorTopicYN="N">Bromocriptine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12618059</ArticleId><ArticleId IdType="pii">S1353802002000937</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001452 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001452 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:12618059
|texte= The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:12618059" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |